Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Operations (Unaudited)

v3.24.0.1
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
3 Months Ended 6 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2023
Dec. 31, 2022
Income Statement [Abstract]        
Revenues $ 18,344,000 $ 17,158,000 $ 33,141,000 $ 34,998,000
Cost of sales 12,676,000 13,050,000 23,162,000 26,942,000
Gross profit 5,668,000 4,108,000 9,979,000 8,056,000
Operating expenses:        
Selling and administrative 4,593,000 4,250,000 9,318,000 8,786,000
Research and development 1,440,000 1,162,000 2,735,000 2,385,000
Total operating expenses 6,033,000 5,412,000 12,053,000 11,171,000
Operating loss (365,000) (1,304,000) (2,074,000) (3,115,000)
Other income 8,000 8,000
Interest income (expense), net (449,000) (385,000) (852,000) (713,000)
Net loss $ (814,000) $ (1,681,000) $ (2,926,000) $ (3,820,000)
Net loss per share - basic $ (0.05) $ (0.10) $ (0.18) $ (0.24)
Net loss per share - diluted $ (0.05) $ (0.10) $ (0.18) $ (0.24)
Weighted average number of common shares outstanding - basic 16,516,700 16,020,183 16,495,727 16,008,740
Weighted average number of common shares outstanding - diluted 16,516,700 16,020,183 16,495,727 16,008,740